At the cellular level, converging evidence from mouse and human studies suggests that microglia play a key role in IFN pathway dysregulation and that microglial dysfunction associates broadly with risk for neurodegenerative diseases like AD (4, 82, 83) and PD (61) alongside sex-specific effects in psychiatric diseases like MDD (66). Here, IFNA1 is linked to Parkinson disease.